Trisalus Life Sciences, Inc.
TLSI
Revenue
7.36M
▲907.00k▲14.05%
3 Months ChangeAssets
32.43M
▲14.54M▲81.29%
3 Months ChangeLiabilities
56.58M
▲3.77M▲7.13%
3 Months ChangeFree Cash Flow
-10.93M
▼-423.00k▼-4.02%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001104659-24-113486
2024-08-15
Form 8-K
ID: 0001104659-24-089936
2024-08-14
Form 10-Q
ID: 0001826667-24-000039
2024-07-01
Form 8-K
ID: 0001104659-24-076841
2024-06-27
Form 8-K
ID: 0001104659-24-075234
2024-05-24
Form 8-K
ID: 0001104659-24-064883
2024-05-15
Form 10-Q
ID: 0001826667-24-000017
2024-05-15
Form 8-K
ID: 0001104659-24-061631
2024-05-07
Form 8-K
ID: 0001104659-24-057985
2024-04-30
Form 8-K
ID: 0001104659-24-055007